Publications by authors named "Geert-Jan Mulder"

Claim this Profile
I
Investing in vision: Innovation in retinal therapeutics and the influence on venture capital investment.
Dmitrij Hristodorov, Tim Lohoff, Nanna Luneborg, Geert-Jan Mulder, Simon J Clark

Prog Retin Eye Res· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study.
Ganesh Raghu, Bernt van den Blink, Mark J Hamblin, A Whitney Brown, Jeffrey A Golden, Geert-Jan Mulder

Lancet Respir Med· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Recombinant Human Pentraxin 2 vs Placebo on Change in Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis: A Randomized Clinical Trial.
Ganesh Raghu, Bernt van den Blink, Mark J Hamblin, A Whitney Brown, Jeffrey A Golden, Geert-Jan Mulder

JAMA· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acquiring orphans.
Rogier Rooswinkel, Geert-Jan Mulder, Sander van Deventer

Nat Biotechnol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Building for big pharma.
Asiya Giniatullina, Marco Boorsma, Geert-Jan Mulder, Sander van Deventer

Nat Biotechnol· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia.
Marina Cavazzana-Calvo, Emmanuel Payen, Olivier Negre, Gary Wang, Kathleen Hehir, Geert-Jan Mulder

Nature· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic and pharmacodynamic evaluation of liposomal amikacin for inhalation in cystic fibrosis patients with chronic pseudomonal infection.
Olanrewaju O Okusanya, Sujata M Bhavnani, Jeffrey Hammel, Predrag Minic, Lieven J Dupont, Geert-Jan Mulder

Antimicrob Agents Chemother· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis